These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 8045741)
1. The effect of shiga toxin and sonicates of Shigella isolates from children with neurologic manifestation on neuroblastoma cell lines. Ashkenazi S; Yuhas Y; Even-Tov S; Kaminsky E; Danon YL Isr J Med Sci; 1994 Aug; 30(8):604-10. PubMed ID: 8045741 [TBL] [Abstract][Full Text] [Related]
2. The association of Shiga toxin and other cytotoxins with the neurologic manifestations of shigellosis. Ashkenazi S; Cleary KR; Pickering LK; Murray BE; Cleary TG J Infect Dis; 1990 May; 161(5):961-5. PubMed ID: 2324546 [TBL] [Abstract][Full Text] [Related]
3. Production, characterization and immunodiagnostic application of a monoclonal antibody to Shiga toxin. Qadri F; Mohi MG; Azim T; Faruque SM; Kabir AK; Albert MJ J Diarrhoeal Dis Res; 1996 Jun; 14(2):95-100. PubMed ID: 8870402 [TBL] [Abstract][Full Text] [Related]
4. Production of Shiga toxin and other cytotoxins by serogroups of Shigella. Bartlett AV; Prado D; Cleary TG; Pickering LK J Infect Dis; 1986 Dec; 154(6):996-1002. PubMed ID: 3537154 [TBL] [Abstract][Full Text] [Related]
5. Interaction of Shiga toxins with human brain microvascular endothelial cells: cytokines as sensitizing agents. Ramegowda B; Samuel JE; Tesh VL J Infect Dis; 1999 Oct; 180(4):1205-13. PubMed ID: 10479149 [TBL] [Abstract][Full Text] [Related]
6. Production of cytotoxins and enterotoxins by strains of Shigella and Salmonella isolated from children with bloody diarrhea. Morales Espinosa RM; González-Valencia G; Muñoz O; Torres J Arch Med Res; 1993; 24(1):13-21. PubMed ID: 8292872 [TBL] [Abstract][Full Text] [Related]
7. Induction of tumor necrosis factor and nitric oxide by Shigella strains isolated from patients with or without neurologic manifestations. Mor M; Yuhas Y; Kaminsky E; Dinari G; Ashkenazi S Isr J Med Sci; 1996 Dec; 32(12):1271-5. PubMed ID: 9007170 [TBL] [Abstract][Full Text] [Related]
9. Towards a vaccine candidate against Shigella dysenteriae 1: expression of the Shiga toxin B-subunit in an attenuated Shigella flexneri aroD carrier strain. Tzschaschel BD; Klee SR; de Lorenzo V; Timmis KN; Guzmán CA Microb Pathog; 1996 Oct; 21(4):277-88. PubMed ID: 8905616 [TBL] [Abstract][Full Text] [Related]
10. Rapid method to detect shiga toxin and shiga-like toxin I based on binding to globotriosyl ceramide (Gb3), their natural receptor. Ashkenazi S; Cleary TG J Clin Microbiol; 1989 Jun; 27(6):1145-50. PubMed ID: 2666433 [TBL] [Abstract][Full Text] [Related]
11. Current aspects of Shigella pathogenesis. Torres AG Rev Latinoam Microbiol; 2004; 46(3-4):89-97. PubMed ID: 17061529 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells. Tesh VL; Samuel JE; Perera LP; Sharefkin JB; O'Brien AD J Infect Dis; 1991 Aug; 164(2):344-52. PubMed ID: 1649877 [TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of Shigella diarrhea. XIV. Analysis of Shiga toxin receptors on cloned HeLa cells. Jacewicz M; Feldman HA; Donohue-Rolfe A; Balasubramanian KA; Keusch GT J Infect Dis; 1989 May; 159(5):881-9. PubMed ID: 2651533 [TBL] [Abstract][Full Text] [Related]
14. Shigella toxin and the pathogenesis of shigellosis. Keusch GT; Donohue-Rolfe A; Jacewicz M Ciba Found Symp; 1985; 112():193-214. PubMed ID: 3847336 [TBL] [Abstract][Full Text] [Related]
15. Environmental and human isolates of Vibrio cholerae and Vibrio parahaemolyticus produce a Shigella dysenteriae 1 (Shiga)-like cytotoxin. O'Brien AD; Chen ME; Holmes RK; Kaper J; Levine MM Lancet; 1984 Jan; 1(8368):77-8. PubMed ID: 6140426 [TBL] [Abstract][Full Text] [Related]
16. Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro. Louise CB; Obrig TG Microvasc Res; 1994 May; 47(3):377-87. PubMed ID: 8084301 [TBL] [Abstract][Full Text] [Related]
17. Release of Shiga toxin from Shigella dysenteriae 1 by polymyxin B. Griffin DE; Gemski P Infect Immun; 1983 Apr; 40(1):425-8. PubMed ID: 6299964 [TBL] [Abstract][Full Text] [Related]
18. Human microvascular endothelial cells are strongly sensitive to Shiga toxins. Ohmi K; Kiyokawa N; Takeda T; Fujimoto J Biochem Biophys Res Commun; 1998 Oct; 251(1):137-41. PubMed ID: 9790920 [TBL] [Abstract][Full Text] [Related]
19. Emergence of Shiga toxin 1 genes within Shigella dysenteriae type 4 isolates from travelers returning from the Island of Hispañola. Gupta SK; Strockbine N; Omondi M; Hise K; Fair MA; Mintz E Am J Trop Med Hyg; 2007 Jun; 76(6):1163-5. PubMed ID: 17556630 [TBL] [Abstract][Full Text] [Related]
20. Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis. O'Brien AD; Tesh VL; Donohue-Rolfe A; Jackson MP; Olsnes S; Sandvig K; Lindberg AA; Keusch GT Curr Top Microbiol Immunol; 1992; 180():65-94. PubMed ID: 1324134 [No Abstract] [Full Text] [Related] [Next] [New Search]